Paper Details

  1. Home
  2. Paper Details

Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir.

Author: , CoatesK M, PatelR, StrandA, WulfH C

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Episodic valaciclovir significantly increased the chance of preventing or aborting painful genital herpes simplex virus (HSV) lesions compared to placebo. This study explores the clinical outcome of aborted lesions and its association with early treatment.
Paper Details　
Original Abstract of the Article :
In prospective trials, episodic valaciclovir significantly increased the chance of preventing or aborting the development of painful vesicular genital herpes simplex virus (HSV) lesions compared with placebo. We explored the clinical outcome of aborted lesions and its association with early treatmen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1136/sti.78.6.435

データ提供：米国国立医学図書館（NLM）

Valaciclovir: A Powerful Weapon Against Genital Herpes

The [herpes simplex virus] (HSV) can cause painful and recurring genital lesions, posing a significant health challenge. This research investigates the efficacy of [valaciclovir] in preventing or aborting the development of these lesions. Previous studies have shown that valaciclovir is effective in preventing outbreaks, and this study further examines the impact of early treatment on the clinical outcome of aborted lesions. The researchers compare the effectiveness of 3-day and 5-day treatment regimens to understand the optimal duration of therapy for preventing or aborting HSV lesions.

Early Treatment: A Key to Preventing Outbreaks

This research underscores the importance of early treatment for [HSV infections]. The study shows that valaciclovir is more effective when administered early in the course of an outbreak. This finding could lead to better management strategies for HSV infections, potentially reducing the frequency and severity of outbreaks.

Valaciclovir: A Lifeline in the Desert of Herpes

Living with HSV can feel like navigating a desert of uncertainty, with unpredictable outbreaks causing pain and discomfort. Valaciclovir provides a vital lifeline, offering a safe and effective treatment option that can help to prevent or abort these outbreaks and improve the quality of life for individuals with HSV.

Dr.Camel's Conclusion

Just as a camel can endure the harsh conditions of a desert, individuals with HSV can find relief and stability with the help of valaciclovir. This research provides valuable insights into the best strategies for managing HSV infections, allowing people to live fulfilling lives despite the challenges posed by this viral disease.

Date :
  1. Date Completed 2003-02-20
  2. Date Revised 2019-05-03
Further Info :

Pubmed ID

12473805

DOI: Digital Object Identifier

10.1136/sti.78.6.435

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.